| SMAD3 |
neural stem cells |
TGFb |
Permissive
|
Mus musculus |
GSE36673
...
|
MA0513.1
...
|
| SMAD3 |
BMDM (bone marrow-derived macrophages) |
vehicle 6h |
Permissive
|
Mus musculus |
GSE72964
...
|
MA0513.1
...
|
| SMAD3 |
BMDM (bone marrow-derived macrophages) |
tissuehomogenate 6h |
Permissive
Robust
|
Mus musculus |
GSE72964
...
|
MA0513.1
...
|
| SMAD3 |
BMDM (bone marrow-derived macrophages) |
TGFb 4h |
Permissive
Robust
|
Mus musculus |
GSE72964
...
|
MA0513.1
...
|
| SMAD3 |
HMLE-Twist-ER (breast cancer) |
Treatment: no CellType: Immortalized human mammary epithelial cells |
Permissive
Robust
|
Homo sapiens |
GSE104760
...
|
MA0513.1
...
|
| SMAD3 |
HMLE-Twist-ER (breast cancer) |
Treatment: TGF-beta CellType: Immortalized human mammary epithelial cells |
Permissive
Robust
|
Homo sapiens |
GSE104760
...
|
MA0513.1
...
|
| SMAD3 |
HMLE-Twist-ER (breast cancer) |
CellType: Immortalized human mammary epithelial cells Treatment: Doxycicline |
Permissive
|
Homo sapiens |
GSE104760
...
|
MA0513.1
...
|
| SMAD3 |
HMLE-Twist-ER (breast cancer) |
CellType: immortalized human mammary epithelial cells Treatment:TGF--beta |
Permissive
Robust
|
Homo sapiens |
GSE104760
...
|
MA0513.1
...
|
| SMAD3 |
MDA-MB-231 (breast adenocarcinoma) |
Treatment: no CellType: Immortalized human mammary epithelial cells |
Permissive
Robust
|
Homo sapiens |
GSE104760
...
|
MA0513.1
...
|
| SMAD3 |
MDA-MB-231 (breast adenocarcinoma) |
Treatment: TGF-beta CellType: Immortalized human mammary epithelial cells |
Permissive
Robust
|
Homo sapiens |
GSE104760
...
|
MA0513.1
...
|
| SMAD3 |
HCC1954 (ductal breast carcinoma) |
Treatment: no CellType: Immortalized human mammary epithelial cells |
Permissive
Robust
|
Homo sapiens |
GSE104760
...
|
MA0513.1
...
|
| SMAD3 |
HCC1954 (ductal breast carcinoma) |
Treatment: TGF-beta CellType: Immortalized human mammary epithelial cells |
Permissive
Robust
|
Homo sapiens |
GSE104760
...
|
MA0513.1
...
|
| SMAD3 |
primary vascular smooth muscle cell (C57BL/6 mice) |
Treatment: infected with shNT for 3 days |
Permissive
|
Mus musculus |
GSE112417
...
|
MA0513.1
...
|
| SMAD3 |
primary vascular smooth muscle cell (C57BL/6 mice) |
Treatment: infected with shNT for 3 days |
Permissive
|
Mus musculus |
GSE112417
...
|
MA0513.1
...
|
| SMAD3 |
primary vascular smooth muscle cell (C57BL/6 mice) |
Treatment: infected with sh2AZ for 3 days |
Permissive
|
Mus musculus |
GSE112417
...
|
MA0513.1
...
|
| SMAD3 |
primary vascular smooth muscle cell (C57BL/6 mice) |
Treatment: infected with sh2AZ for 3 days |
Permissive
|
Mus musculus |
GSE112417
...
|
MA0513.1
...
|
| SMAD3 |
HCASMC (Human coronary artery smooth muscle cells) |
CellLine: A549 |
Permissive
|
Homo sapiens |
GSE115317
...
|
MA0513.1
...
|
| SMAD3 |
MDA-MB-231 (breast adenocarcinoma) |
Treatment: Untreated |
Permissive
|
Homo sapiens |
GSE92443
...
|
MA0513.1
...
|
| SMAD3 |
MDA-MB-231 (breast adenocarcinoma) |
Treatment: 2 ng/mLTGF beta, 1 hr |
Permissive
Robust
|
Homo sapiens |
GSE92443
...
|
MA0513.1
...
|
| SMAD3 |
embryonic fibroblasts |
Treatment: + 1 ug/ml doxycycline Genotype: Smad3CA expression Source: day 3 of reprogramming |
Permissive
|
Mus musculus |
GSE85177
...
|
MA0513.1
...
|
| SMAD3 |
embryonic fibroblasts |
Treatment: no Genotype: Smad3CA expression Source: day 3 of reprogramming |
Permissive
|
Mus musculus |
GSE85177
...
|
MA0513.1
...
|
| SMAD3 |
striatum |
Strain: C57BL/6J Age: 4 months Genotype: wildtype Sex: male |
Permissive
|
Mus musculus |
GSE88775
...
|
MA0513.1
...
|
| SMAD3 |
striatum |
Strain: C57BL/6J Age: 4 months Genotype: Q111/+ Sex: male |
Permissive
|
Mus musculus |
GSE88775
...
|
MA0513.1
...
|
| SMAD3 |
PC3(bone mets prostate adenocarcinoma) |
Treatment: hypoxia (0.2% O2); |
Permissive
Robust
|
Homo sapiens |
GSE106305
...
|
MA0513.1
...
|
| SMAD3 |
embryonic stem cell-drived neuroepithelial cells |
|
Permissive
|
Mus musculus |
GSE76557
...
|
MA0513.1
...
|
| SMAD3 |
|
|
Permissive
|
Homo sapiens |
GSE21614
|
MA0795.1
|
| SMAD3 |
|
|
Permissive
|
Homo sapiens |
GSE29422
|
MA0795.1
|
| SMAD3 |
hESC-1 (Embryonic stem cells) |
|
Permissive
|
Homo sapiens |
GSE29422
|
MA0795.1
|
| SMAD3 |
|
|
Permissive
|
Homo sapiens |
GSE68325
|
MA0795.1
|
| SMAD3 |
|
DIFF_0H |
Permissive
|
Homo sapiens |
GSE36578
|
MA0795.1
|
| SMAD3 |
|
DIFF_2H |
Permissive
|
Homo sapiens |
GSE36578
|
MA0795.1
|
| SMAD3 |
|
DIFF_48H |
Permissive
|
Homo sapiens |
GSE36578
|
MA0795.1
|
| SMAD3 |
LX-2 (hepatic stellate cells) |
CALCIPOTRIOL_TGFB1 |
Permissive
|
Homo sapiens |
GSE38103
|
MA0795.1
|
| SMAD3 |
LX-2 (hepatic stellate cells) |
TGFB1 |
Permissive
|
Homo sapiens |
GSE38103
|
MA0795.1
|
| SMAD3 |
NCI-H441 (squamous cell lung carcinoma ) |
SIITTF1 |
Permissive
|
Homo sapiens |
GSE51509
|
MA0795.1
|
| SMAD3 |
hESC-1 (Embryonic stem cells) |
DIFF_D0 |
Permissive
|
Homo sapiens |
GSE75297
|
MA0795.1
|
| SMAD3 |
hESC-1 (Embryonic stem cells) |
DIFF_D1 |
Permissive
|
Homo sapiens |
GSE75297
|
MA0795.1
|
| SMAD3 |
hESC-1 (Embryonic stem cells) |
DIFF_D2 |
Permissive
|
Homo sapiens |
GSE75297
|
MA0795.1
|
| SMAD3 |
|
|
Permissive
|
Homo sapiens |
GSE36578
|
MA0795.1
|
| SMAD3 |
NCI-H441 (squamous cell lung carcinoma ) |
|
Permissive
|
Homo sapiens |
GSE51509
|
MA0795.1
|
| SMAD3 |
hESC-1 (Embryonic stem cells) |
|
Permissive
|
Homo sapiens |
GSE75297
|
MA0795.1
|
